FDA approves MedImmune’s nasal spray flu vaccine FluMist

Pallavi Madhiraju- September 20, 2024 0

The U.S. Food and Drug Administration has approved FluMist, a nasal spray flu vaccine by MedImmune LLC, for self-administration or caregiver-administration. This marks a significant ... Read More

FDA extends approval for GSK’s RSV vaccine, AREXVY, to adults aged 50-59 at increased risk

Pallavi Madhiraju- June 9, 2024 0

The U.S. Food and Drug Administration (FDA) has officially broadened the age indication for GSK plc's (LSE/NYSE: GSK) AREXVY, marking it as the first adjuvanted ... Read More

Understanding Chronic Obstructive Pulmonary Disease (COPD): A comprehensive guide

Pallavi Madhiraju- March 10, 2024 0

Chronic Obstructive Pulmonary Disease, or COPD, is a progressive lung condition that encompasses emphysema and chronic bronchitis, often leading to severe respiratory issues. Affecting approximately ... Read More